CD4 and neoplasm: In the setting of cancer, MHC molecules play the pivotal role of presenting processed tumor antigens to CD4 and CD8 lymphocytes in order to generate a tumor-specific cytotoxic response (Seliger, 2008b; Hastings, 2013).